# agilon health, inc. (AGL) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from agilon health, inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/AGL/mda/fy2025/): filed 2026-02-25; accession 0001628280-26-011655 (https://www.sec.gov/Archives/edgar/data/1831097/000162828026011655/agl-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/AGL/mda/fy2024/): filed 2025-02-25; accession 0001628280-25-007721 (https://www.sec.gov/Archives/edgar/data/1831097/000162828025007721/agl-20241231.htm)
- [FY 2023 MD&A](/company/AGL/mda/fy2023/): filed 2024-02-27; accession 0001628280-24-007242 (https://www.sec.gov/Archives/edgar/data/1831097/000162828024007242/agl-20231231.htm)
- [FY 2022 MD&A](/company/AGL/mda/fy2022/): filed 2023-03-01; accession 0000950170-23-005541 (https://www.sec.gov/Archives/edgar/data/1831097/000095017023005541/agl-20221231.htm)
- [FY 2021 MD&A](/company/AGL/mda/fy2021/): filed 2022-03-03; accession 0000950170-22-002826 (https://www.sec.gov/Archives/edgar/data/1831097/000095017022002826/agl-20211231.htm)

Back to /company/AGL/